Benzodiazepines for the long-term treatment of anxiety disorders? - Authors' reply
- PMID: 34246346
- PMCID: PMC9092619
- DOI: 10.1016/S0140-6736(21)00931-4
Benzodiazepines for the long-term treatment of anxiety disorders? - Authors' reply
Conflict of interest statement
We declare no competing interests.
Comment on
-
Anxiety disorders.Lancet. 2021 Mar 6;397(10277):914-927. doi: 10.1016/S0140-6736(21)00359-7. Epub 2021 Feb 11. Lancet. 2021. PMID: 33581801 Free PMC article. Review.
-
Benzodiazepines for the long-term treatment of anxiety disorders?Lancet. 2021 Jul 10;398(10295):119-120. doi: 10.1016/S0140-6736(21)00934-X. Lancet. 2021. PMID: 34246344 No abstract available.
References
-
- Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet 2019; 393: 768–77. - PubMed
-
- National Institute for Health and Care Excellence. Anxiety disorders. 2014. https://www.nice.org.uk/guidance/qs53/resources/anxiety-disorders-pdf-20... (accessed April 9, 2021).
-
- US Food and Drug Administration. FDA requiring boxed warning updated to improve safe use of benzodiazepine drug class. Sept 29, 2020. https://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-requiring-boxed-w... (accessed April 9, 2021).
